Home

Jean George

CIK 1291804 · last filed 2024-02-16

Jean George is a corporate insider who has filed 43 SEC Form 4 insider transactions across 8 companies since 2007. The most recent filing shows the insider exercised options covering $23.9K of CYT on Feb 16, 2024. Across all open-market trades the lifetime net is −$34.4M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $599.9K across reported positions. 11 SEC filings were submitted jointly with Zeltiq Aesthetics Inc.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$599.9K

Companies

8

Total Filings

43

Lifetime Open-Market Net

-$34.38M

Filer Profile

Reported Address
3270 ALPINE RD.
PORTOLA VALLEY, CA 94028
Related Filers
Zeltiq Aesthetics Inc — 11 joint filings, latest 2015-07-23
Lightstone Ventures II, L.P. — 7 joint filings, latest 2025-08-05
Henry A Plain JR — 6 joint filings, latest 2025-08-05
Michael A Carusi — 5 joint filings, latest 2021-12-15
LSV Associates, LLC — 5 joint filings, latest 2021-12-15
Lightstone Ventures (A), L.P. — 5 joint filings, latest 2021-12-15
ADVANCED TECHNOLOGY VENTURES VII LP — 3 joint filings, latest 2011-10-18
ATV Entrepreneurs VII, L.P. — 3 joint filings, latest 2011-10-18
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Cyteir Therapeutics, Inc. (CYT) Delisted Director 2,458,415 $3.02 $7.42M $0 4 2024-02-16
Calithera Biosciences, Inc. (CALA) Delisted Director 90,504 $0.00 $27 $3.00M 8 2021-06-14
ALXO 10%+ Owner 309,222 $1.94 $599.9K $68.40M 1 2020-07-22
ACCELERON PHARMA INC (XLRN) Delisted Director 5,127 $178.75 $916.5K -$57.46M 15 2020-01-24
Astria Therapeutics, Inc. (CATB) Delisted Director 15,127 $8.54 $129.2K $3.11M 4 2018-06-07
Zeltiq Aesthetics Inc (ZLTQ) Delisted Director 5,786 — — -$51.43M 9 2015-07-23
PORTOLA PHARMACEUTICALS INC (PTLA) Delisted Director 27,939 — — $0 1 2013-05-30
CORNERSTONE THERAPEUTICS INC (CRTX) Delisted Director — $1.95 — $0 1 2007-05-03

Recent Filings

43 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2024-02-16 Cyteir Therapeutics, Inc. (CYT) Delisted Exer (M) +14,150 $23.9K EDGAR
2023-02-07 Cyteir Therapeutics, Inc. (CYT) Delisted Grant (A) — $0 EDGAR
2022-02-24 Cyteir Therapeutics, Inc. (CYT) Delisted Grant (A) — $0 EDGAR
2021-06-24 Cyteir Therapeutics, Inc. (CYT) Delisted Conv (C) +2,444,268 $0 EDGAR
2021-06-14 Calithera Biosciences, Inc. (CALA) Delisted Grant (A) — $0 EDGAR
2020-07-22 ALXO Mixed +36,820,539 $68.40M EDGAR
2020-06-11 Calithera Biosciences, Inc. (CALA) Delisted Grant (A) — $0 EDGAR
2020-01-24 ACCELERON PHARMA INC (XLRN) Delisted Grant (A) +1,377 $0 EDGAR
2019-06-28 ACCELERON PHARMA INC (XLRN) Delisted Mixed — -$504.1K EDGAR
2019-06-03 Calithera Biosciences, Inc. (CALA) Delisted Grant (A) — $0 EDGAR
Showing 1–10 of 43
Page 1 of 5
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.